News

MUSC Parkinson's Foundation Center of Excellence along with multiple sponsors hosted the highly anticipated Passion for Parkinson’s event.

Trauma and intimate partner violence continue to be neglected as contributors to opioid use disorder. A new digital toolkit aims to change that.

The American Cancer Society awarded Hollings researcher David Long, Ph.D., a Catalyst grant to study how two proteins' interaction affects genomic instability.

Anti-malarial drug shows promise against cancer, but resistance often develops. A Hollings team found out how, setting stage for combination therapies.

Not enough people are aware of lung cancer screening, even though the test can find early-stage, treatable cancer, Hollings researchers find.

Quitting smoking soon after a cancer diagnosis adds an average of two years to a patient's life, a new study finds.

An international collaboration has advanced therapies for co-occurring substance use disorders and PTSD and helped to inform prevention efforts globally.

A new study from MUSC Hollings Cancer Center shows how a receptor called PPAR δ helps disable the immune system so that T-cells can’t kill cancer cells.

MUSC hosts a New Faculty Research Orientation, providing faculty with essential resources and insights to excel.

Models help scientists understand how cancer develops - but researchers haven't had one for most ovarian cancers.